Targeting RBPMS selectively eliminates FOXO1-mediated stem cell signatures in mouse models of acute myeloid leukemia.
Liu P, Zhang S, Chen BY, Chang B, Jiang Y, Li X, Chen X, Li ZJ, Yang R, Wang X, Xu CH, Liu X, Liu N, Jia Y, Yu PC, Wang Y, Zong LJ, Hu CL, Hou H, Cao D, Li X, Deng CH, Ren YY, Zhao MY, Ma X, Cui R, Teng D, Chen M, Wang R, Jin J, Jiang SY, Yan X, Xue K, Zhang Q, Li J, Dai E, Shen S, Wang Z, Ye X, Zhang J, Liu Y, Cui W, Lu M, Zhao WL, Chang CK, He PC, Chen Z, Chen SJ, Zheng M, Sun XJ, Wang L.
Liu P, et al. Among authors: hou h.
Sci Transl Med. 2026 May 6;18(848):eadv8951. doi: 10.1126/scitranslmed.adv8951. Epub 2026 May 6.
Sci Transl Med. 2026.
PMID: 42090480